DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”
DCB is thrilled to be featured in the Nature Portfolio Spotlight on Switzerland. The article “Cutting-edge diabetes technology to make lives easier” dives into our work at DCB and outlines significant advancements in diabetes management.
Cutting-edge diabetes technology to make lives easier
The renowned Nature Portfolio has issued a Spotlight on Switzerland with the motto: “Switzerland has enjoyed a warm relationship with the rest of Europe for decades – but how has that influenced the research done in the country?”
DCB is thrilled to be featured in this Spotlight, shining a light on diabetes technology research and innovation.
Our assistant professors José García-Tirado and Lilian Witthauer, as well as our scientific program manager Martina Rothenbühler were interviewed, providing insights into their work at DCB and the development of technologies such as the artificial pancreas, which promises to transform the daily lives of people with diabetes by simplifying insulin management.
Read the article now to dive deeper into our work and see how innovative technologies are shaping the future of diabetes management.
More recent news
DT-Report 2026: Join now
The survey for the DT Report 2026 is now available – Take part and help shape the future of diabetes technology with...
Alva Innovation wins the DCB Open Innovation Challenge 2025
Bern, 6 November 2025 - The start-up Alva Innovations has won first place in the DCB Open Innovation Challenge. The...
A Day of Innovation: Swiss Diabetes Technology and Beyond
Join us on 5 November 2025 at sitem-insel, Bern for a day dedicated to inspiring ideas and new perspectives in perspectives in medtech, diabetes technology and beyond.



